He said the Swiss government would not agree to a full waiver of the rights but it was willing to continue discussions.
Parmelin was speaking on the sidelines of a meeting of the World Trade Organization (WTO)External link in the Swiss city of Geneva on Wednesday as the conference was extended by one day to reach a consensus on changes to global trade rules.
“It’s not part of Switzerland’s policy to leave a discussion,” Parmelin was quoted as saying by the Keystone-SDA news agency.
He added that it was in nobody’s interest to block negotiations and some of the 164 WTO member states were holding their cards close to their chests.
Nevertheless, Parmelin said a deal was still possible, but he dismissed a proposal by non-governmental organisations for a temporary waiver of IP rights.
Any departure from basic principles in the IP rights was inacceptable for Switzerland’s pharmaceutical industry, he explained.
India, South Africa and other developing countries have sought exceptions for vaccines, treatments and diagnostics for more than a year, but they came up against opposition from Switzerland and Britain. Both countries have major pharmaceutical producers.
The WTO ministerial meeting, originally due to end on Wednesday, is the first major conference in four years.
More
More
Will WTO break deadlock in next major meeting?
This content was published on
The 12th Ministerial Conference of the World Trade Organization (WTO), postponed twice due to Covid, will finally take place from Sunday in Geneva.
Swiss President Karin Keller-Sutter makes official visit to Austria
This content was published on
Karin Keller-Sutter, who took over the rotating Swiss presidency this year, has made her first official visit abroad as president to Austria.
This content was published on
The boss of Swiss Post, Roberto Cirillo, is stepping down at the end of March after six years in the job, the company announced on Friday.
This content was published on
The name and logo of the former Credit Suisse headquarters at Paradeplatz 8 in Zurich's financial centre were officially replaced by those of UBS on Friday.
Outgoing Swiss federal police chief warns of insufficient resources
This content was published on
The outgoing director of the Federal Office of Police (Fedpol), Nicoletta della Valle, has warned that officers, prosecutors and investigators in Switzerland have insufficient resources to do their work.
Swiss university inaugurates Europe’s most powerful centrifuge
This content was published on
The federal technology institute ETH Zurich has inaugurated Europe's most powerful geotechnical centrifuge. Researchers use the instrument to simulate the effects of natural hazards.
Swiss film industry reports successful year in 2024
This content was published on
Swiss films did well in cinemas in 2024, recording over 907,000 admissions, the Federal Statistical Office (FSO) reports. They accounted for almost 9% of all films shown last year in Switzerland.
Glencore and Rio Tinto held talks on mining’s biggest-ever potential merger, say reports
This content was published on
The Swiss-based mining and commodities group Glencore and the British company Rio Tinto reportedly held early-stage talks last year about combining their businesses.
First municipalities begin Swiss-wide plastic packaging recycling scheme
This content was published on
A new collection system to recycle plastic packaging and drinks cartons has begun in a handful of Swiss municipalities - others should follow in the coming weeks.
This content was published on
Despite an ongoing restructuring programme, Swiss retail giant Migros continued to grow last year by 1.6%, posting record sales of CHF32.5 billion ($35.7 billion).
Swiss researchers warn ‘mega-droughts’ are spreading around the world
This content was published on
"Mega-droughts" are increasing worldwide - becoming more frequent, hotter and more widespread over the past 40 years, a study published on Thursday shows.
Swiss open to compromise in Covid vaccine talks at WTO
This content was published on
Switzerland is open to compromise in talks on the IP rights of Covid-19 vaccines and drugs at the World Trade Organization.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.